profit from every $100 of sales.
$0$100
ICU Medical
$178.26-2.11% today
+24.5% in 1 year
1-year low $115.451-year high $187.26
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $6,090.57 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What ICU Medical sold, what it kept, and what it did with the cash.
Sales went from $2.28 billion in 2022 to $2.23 billion in 2025, with $732,000 of profit last year.
SalesProfit
ICU Medical handed back 11% of the cash it generated last year.
Buybacks $9M
Free cash flow 2025$83M
Bought back its own shares$9M
Paid as dividends–
Cash vs. debt$308M vs. $1.3B
ICU Medical vs. similar companies
ICU Medical grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| ICU Medical | 6,090.6× · Very expensive | ||
 Intuitive Surgical | 54.6× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 34.8× · Expensive | ||
 Medline | 47.9× · Expensive |
AI analysis
An AI analyst reads ICU Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 1,271 | 1,316 | 2,280 | 2,259 | 2,382 | 2,231 | |
| 461 | 491 | 698 | 740 | 825 | 822 | |
| – | – | -4 | 48 | 97 | 109 | |
| 185 | 172 | 192 | 253 | 260 | 298 | |
| 87 | 103 | -74 | -30 | -118 | 1 | |
| 4.02 | 4.74 | -3.11 | -1.23 | -4.83 | 0.03 | |
| 36.3% | 37.3% | 30.6% | 32.8% | 34.6% | 36.8% | |
| – | – | -0.2% | 2.1% | 4.1% | 4.9% | |
| 6.8% | 7.8% | -3.3% | -1.3% | -4.9% | 0.0% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 1,764 | 1,881 | 4,516 | 4,378 | 4,204 | 4,051 |
| Cash | 396 | 553 | 209 | 254 | 309 | 308 |
| Total debt | – | – | 1,734 | 1,704 | 1,626 | 1,332 |
| Total liabilities | – | – | 2,426 | 2,255 | 2,239 | 1,927 |
| 1,502 | 1,616 | 2,090 | 2,123 | 1,965 | 2,124 | |
| 22 | 22 | 24 | 24 | 24 | 25 | |
| 5.2% | 4.0% | -0.9% | 0.5% | 0.9% | 2.2% | |
| 5.8% | 6.4% | -3.6% | -1.4% | -6.0% | 0.0% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 223 | 268 | -62 | 166 | 204 | 180 | |
| – | – | 99 | 94 | 90 | 97 | |
| – | – | -161 | 73 | 114 | 83 | |
| Dividends paid | – | – | – | – | – | – |
| 13 | 8 | 11 | 9 | 12 | 9 | |
| 24 | 27 | 36 | 41 | 47 | 56 |
Valuation
- 6,090.6×
- 22.1×
- –
- 1.9×
- 2.0×
- 53.8×
- 18.4×
- 1.9%
- 0.0%
- 0.0%
Profitability
- 36.8%
- 4.9%
- 0.0%
- 14.6%
- 2.3%
- 0.7%
- 2.2%
- 1.2%
- 2.3%
- 4.0%
Growth
- +11.9%
- −62.5%
- −26.4%
- –
- +1.4%
Financial health
- 3.4×
- 0.63
- 33.4%
- 1.0×
- 2.39
- 1.13
- 0.54
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 39%of 958
Bottom 36%of 888
Top 46%of 889
Top 44%of 987
What analysts expect
- Average price target
- $163.50
- Range
- $163.00 – $164.00
- 4 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | 1.97 | 1.78 | +10.7% |
| Feb 19, 2026 | 1.91 | 1.68 | +13.7% |
| Nov 6, 2025 | 2.03 | 1.43 | +42.0% |
| Aug 7, 2025 | 2.10 | 1.44 | +45.8% |
| May 8, 2025 | 1.72 | 1.23 | +39.8% |
| Feb 27, 2025 | 2.11 | 1.48 | +42.6% |
| Nov 12, 2024 | 1.59 | 1.25 | +27.2% |
| Aug 7, 2024 | 1.56 | 0.98 | +59.2% |
News
Seastar Medical anticipates NEUTRALIZE-AKI enrollment completion by midyear 2027 while preparing modular PMA submissionsSeeking Alpha · Nov 11, 2026Orthofix Medical Inc. Q3 2026 Earnings Call SummaryYahoo Finance · Nov 9, 2026Icu Medical signals 2026 results toward high end of $415M-$435M EBITDA and $8.60-$9 EPS range as logistics consolidation normalizesSeeking Alpha · Nov 5, 2026Tactile Medical targets $50M-$52M adjusted EBITDA in 2026 while maintaining $360M-$366M revenue outlookSeeking Alpha · Nov 3, 2026Medicare used AI to pre-approve patient care, and it immediately led to a large drop in medical servicesMarketWatch · Oct 31, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
25No pass
Benjamin Graham
45No pass
Philip Fisher
26No pass
Peter Lynch
26No pass
Joel Greenblatt
0No pass
Charlie Munger
20No pass
Terry Smith
24No pass
Questions about ICU Medical
Is ICU Medical a good stock to buy?
A business with weak numbers, priced as if everything goes right. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the ICU Medical AI analysis
What does ICU Medical do?
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It is in Medical Instruments & Supplies, based in San Clemente, CA, United States, with 13,000 employees.
Does ICU Medical pay a dividend?
No. ICU Medical does not pay a dividend at the moment; in 2025 it returned $8.77 million to shareholders by buying back its own shares.
Is ICU Medical stock halal?
Yes. ICU Medical passes our halal screen: its business is permitted and its debt is 30% of its market value, under the 30% limit. How we check
How has ICU Medical stock done over the past year?
Up 24.5% over the past twelve months, to $178.26. It traded between $115.45 and $187.26 and is 4.8% below its high.
Who are ICU Medical's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with ICU Medical's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.